Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 3031 Records) |
Query Trace: Ovarian Cancer[original query] |
---|
Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. JAMA network open 2024 9 7 (9): e2431427. Zoulikha Rezoug, Stephanie P Totten, David Szlachtycz, Adrienne Atayan, Kristen Mohler, Sophie Albert, Leila Feng, Brianna Lemieux Anglin, Zhen Shen, Daniel Jimenez, Nancy Hamel, Nicholas Meti, Khashayar Esfahani, Jean-François Boileau, Ipshita Prakash, Mark Basik, Sarkis Meterissian, Francine Tremblay, David Fleiszer, Dawn Anderson, George Chong, Stephanie M Wong, William D Foulk |
Somatic mutation of targeted sequencing identifies risk stratification in advanced ovarian clear cell carcinoma. Gynecologic oncology 2024 9 191 56-66. Shimeng Wan, Yang Gao, Sisi Wu, Hua Wang, Jiyu Tong, Wei Wei, Hang Ren, Danni Yang, Hao He, Hong Ye, Hongbing C |
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer. JAMA oncology 2024 9 . Soyoung Kwak, Chan Wang, Mykhaylo Usyk, Feng Wu, Neal D Freedman, Wen-Yi Huang, Marjorie L McCullough, Caroline Y Um, Martha J Shrubsole, Qiuyin Cai, Huilin Li, Jiyoung Ahn, Richard B Hay |
Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study. Cell transplantation 2024 9 33 9636897241281869. Yu-Hsun Chang, Kun-Chi Wu, Kai-Hung Wang, Dah-Ching Di |
Screening Familial Risk for Hereditary Breast and Ovarian Cancer. JAMA network open 2024 9 7 (9): e2435901. Daniel Kiser, Gai Elhanan, Alexandre Bolze, Iva Neveux, Karen A Schlauch, William J Metcalf, Elizabeth T Cirulli, Catherine McCarthy, Leslie A Greenberg, Savanna Grime, Jamie M Schnell Blitstein, William Plauth, Joseph J Grzyms |
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type. Frontiers in oncology 2024 9 14 1412807. Roberto Buonaiuto, Giuseppe Neola, Aldo Caltavituro, Alessandra Longobardi, Federica Pia Mangiacotti, Amedeo Cefaliello, Maria Rosaria Lamia, Francesco Pepe, Jole Ventriglia, Umberto Malapelle, Giancarlo Troncone, Mario Giuliano, Grazia Arpino, Sandro Pignata, Carmine De Angel |
Identification of ubiquitin markers for survival and prognosis of ovarian cancer. Heliyon 2024 9 10 (18): e37288. Yiwen Feng, Liyun Shan, Yanping Gong, Wenzhao Hang, Zhenyu Sang, Yunyan Sun, Kefu Tang, Yulan Wang, Binjie Hu, Xiaowei |
Evaluation of the Oncomine Comprehensive Assay Plus NGS Panel and the OncoScan CNV Assay for Homologous Recombination Deficiency Detection. Molecular diagnosis & therapy 2024 9 . Lone Schejbel, Tim Svenstrup Poulsen, Lau Kræsing Vestergaard, Ib Jarle Christensen, Estrid Høgda |
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. Hereditary cancer in clinical practice 2024 9 22 (1): 19. Milena Matuszczak, Adam Kilja?czyk, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Cezary Cybulski, Tadeusz D?bniak, Gronwald Jacek, Tomasz Huzarski, Marcin Lener, Anna Jakubowska, Sandra Pietrzak, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Rodney Scott, Steven Narod, Jan Lubi?s |
Improving on polygenic scores across complex traits using select and shrink with summary statistics (S4) and LDpred2. BMC genomics 2024 9 25 (1): 878. Jonathan P Tyrer, Pei-Chen Peng, Amber A DeVries, Simon A Gayther, Michelle R Jones, Paul D Pharo |
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 9 JCO2400668. Antonio González-Martín, María Jesús Rubio, Florian Heitz, René Depont Christensen, Nicoletta Colombo, Toon Van Gorp, Margarita Romeo, Isabelle Ray-Coquard, Lydia Gaba, Alexandra Leary, Luis Miguel De Sande, Coriolan Lebreton, Andrés Redondo, Michel Fabbro, Maria-Pilar Barretina Ginesta, Philippe Follana, J Alejandro Pérez-Fidalgo, Manuel Rodrigues, Ana Santaballa, Renaud Sabatier, Maria José Bermejo-Pérez, Jean-Pierre Lotz, Beatriz Pardo, Gloria Marquina, Luisa Sánchez-Lorenzo, María Quindós, Purificación Estévez-García, Eva Guerra Alía, Luis Manso, Victoria Casado, Stefan Kommoss, Germana Tognon, Stéphanie Henry, Ilan Bruchim, Ana Oaknin, Frédéric Sel |
Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors. Journal of the National Cancer Center 2024 9 4 (3): 280-287. Diwei Zhao, Anqi Wang, Yuanwei Li, Xinyang Cai, Junliang Zhao, Tianyou Zhang, Yi Zhao, Yu Dong, Fangjian Zhou, Yonghong Li, Jun Wa |
Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. Cancers 2024 9 16 (17): . Ava Kwong, Cecilia Y S Ho, Henry C M Leung, Amy W S Leung, Chun-Hang Au, Edmond S K |
Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study. Annals of medicine 2024 9 56 (1): 2399759. Yi Li, Xiaomin Xiong, Xiaohua Liu, Mengke Xu, Boping Yang, Xiaoju Li, Yu Li, Bo Lin, Bo |
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance. Molecular cancer 2024 8 23 (1): 158. Ksenija Nesic, John J Krais, Yifan Wang, Cassandra J Vandenberg, Pooja Patel, Kathy Q Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, , Anna DeFazio, David D L Bowtell, Thomas C Harding, Kevin Lin, Elizabeth M Swisher, Olga Kondrashova, Clare L Scott, Neil Johnson, Matthew J Wakefie |
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in medicine : official journal of the American College of Medical Genetics 2024 8 101230. Robert D Morgan, George J Burghel, Nicola Flaum, Helene Schlecht, Andrew R Clamp, Jurjees Hasan, Claire Mitchell, Zena Salih, Sarah Moon, Martin Hogg, Rosemary Lord, Claire Forde, Fiona Lalloo, Emma R Woodward, Emma J Crosbie, Stephen S Taylor, Gordon C Jayson, D Gareth R Eva |
Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis. BMC cancer 2024 8 24 (1): 1059. Chao Zhou, Yunke Yang, Lu Shen, Lu Wang, Juan Zhang, Xi |
The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study. Frontiers in microbiology 2024 8 15 1417904. Yajun Xiong, Xiaonan Zhang, Xiaoya Niu, Long Zhang, Yanbing Sheng, Aiguo |
Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report. Gynecologic oncology 2024 8 190 104-112. Erik Škof, Vida Stegel, Vita Šetraj?i? Dragoš, Ana Blatnik, Brigita Gregori?, Petra Škerl, Gašper Klan?ar, Anja Zagožen Klasinc, Alenka Bomba?, Mateja Krajc, Srdjan Novakov |
The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in Saccharomyces cerevisiae. microPublication biology 2024 8 2024 . Sherrice Law, David Park, Hannah Park, Hannah Zhang, Damon Mey |
Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer. Frontiers in molecular biosciences 2024 8 11 1426274. Weiwei Gong, Mingqin Kuang, Hongxi Chen, Yiheng Luo, Keli You, Bin Zhang, Yueyang L |
Marginal Contribution of Pathogenic RAD51D Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients. Journal of cancer & allied specialties 2024 8 10 (2): 617. Noor Muhammad, Muhammad Sohail Afzal, Ute Hamann, Muhammad Usman Rash |
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer medicine 2024 8 13 (16): e70103. Jana Soukupova, Barbora Stastna, Madiha Kanwal, Jan Hojny, Petra Zemankova, Marianna Borecka, Leona Cerna, Marta Cerna, Monika Cerna, Vaclava Curtisova, Tatana Dolezalova, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Lucie Hruskova, Stepan Chvojka, Marketa Janatova, Maria Janikova, Sandra Jelinkova, Pavel Just, Marta Kalousova, Petra Kleiblova, Marcela Kosarova, Monika Koudova, Jan Kral, Michaela Krausova, Vera Krutilkova, Eva Machackova, Katerina Matejkova, Renata Michalovska, Petr Nehasil, Barbora Nemcova, Jan Novotny, Matous Palek, Pavel Pesek, Marketa Safarikova, Ondrej Scheinost, Drahomira Springer, Lenka Stolarova, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Eva Tureckova, Kamila Vesela, Zdenka Vlckova, Michal Vocka, Tomas Zima, Libor Macurek, Zdenek Kleibl, |
Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods. Pathology oncology research : POR 2024 8 30 1611813. László Baráti, Anita Maász, Alexandra Mikó, Éva Bércesi, Sultan Al Kalbani, Judit Bene, Sebestyén Kovács, László Mangel, Kinga Hadzsi |
Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
Genetically predicted blood metabolites mediate relationships between gut microbiota and ovarian cancer: a Mendelian randomization study. Frontiers in cellular and infection microbiology 2024 10 14 1451880. Liang Zhang, Tao Cao, Kang Liu, Pengyu Sun, Wenhao Wang, Jiani G |
Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast cancer research and treatment 2024 10 . Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamu |
Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta?analysis. Oncology letters 2024 10 28 (6): 556. Tan Minh Le, Hong Duc Thi Nguyen, Junghwan Cho, Nora Jee-Young Park, Hyung Soo Han, Gun Oh Chong, Incheol S |
- Page last reviewed:Feb 1, 2024
- Content source: